Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02761694 |
| Title | ARQ 751 as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | ArQule |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | United States | Details | |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| Charleston Hematology Oncology | Charleston | South Carolina | 29414 | United States | Details | |
| The Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |